We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

How low can the Standard Life share price go?

Roland Head runs the numbers on Standard Life Aberdeen plc (LON:SLA) and considers a smaller rival.

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

Investors who bought shares of Standard Life Aberdeen (LSE: SLA) expecting a stable share price and a regular income may feel disappointed.

These shares have fallen by about 25% since the merger between Standard Life and Aberdeen Asset management completed in August 2017. With the stock now yielding 7% — often a warning sign of problems ahead — shareholders may be wondering how much further the shares will fall.

Should you buy aberdeen group shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

Standard Life Aberdeen has come up on my own value investing screens recently. I haven’t hit the buy button yet, but I am getting close. Today I’ll explain why I think these shares could offer serious value.

Two overlooked events

Things have changed since last year’s merger. One big change is that the group’s insurance business has been sold to FTSE 250 firm Phoenix, in a deal valued at £3.24bn. The sale saw Standard receive a 19.99% shareholding in Phoenix and a cash payment of £2.34bn.

Management intends to return a total of £1.75bn of this cash to shareholders, via £750m of buybacks and a £1bn B share scheme (worth about 34p per share in cash). In addition, Standard Life Aberdeen is left with a shareholding in Phoenix that’s worth about £1bn.

A second change is that in August, India’s HDFC Asset Management Company floated on the Bombay Stock Exchange. Standard has a 30% shareholding in this business, which was worth about £1.3bn following the flotation.

Too cheap to ignore?

If we deduct the value of the Phoenix and HDFC investment holdings from Standard Life Aberdeen’s £9.4bn market cap, we get a valuation of around £7.1bn for the group’s remaining asset management business.

This part of the business is expected to generate adjusted net earnings of over £700m this year, putting the shares on a 2018 forecast P/E of about 10, with an expected dividend yield of 7%.

Although the group is still struggling with fund outflows, I believe the shares are probably too cheap at this level. I may buy a few for my own share portfolio.

A small-cap alternative yielding 6%+

If you feel that large companies like Standard Life Aberdeen are hard to understand and slow to turn around, then you might want to consider City of London Investment Group (LSE: CLIG) instead.

Like Aberdeen Asset Management, this £109m group has historically focused on emerging markets. Results out today show that funds under management rose by 10% to $5.1bn last year.

Revenue was 8% higher at £33.9m, while pre-tax profit was 10% higher, at £12.8m. Shareholders will receive a total dividend of 27p per share, an increase of 8% from last year.

This payout gives the stock a dividend yield of 6.7%, underlying the group’s core attraction for investors.

An under-the-radar star?

Today’s results include a handy summary of the company’s performance since its flotation in 2006. The shares have risen by 123% from an issue price of 180p to 403p today. But regular generous dividends mean the total return to shareholders since listing is now 377%.

This is a very impressive performance over 12 years, in my opinion.

For income investors who are worried that they might miss out on capital gains, this proven small-cap performer could be worth considering. I’d certainly be happy to add these shares to my own portfolio.

Roland Head has no position in any of the shares mentioned. The Motley Fool UK has recommended Standard Life Aberdeen. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Close-up as a woman counts out modern British banknotes.
Investing Articles

With a 6.4% yield and P/E of 10 is this FTSE dividend stock a hidden passive income gem?

Building a portfolio of solid UK dividend stocks isn't hard. Paul Summers takes a closer look at one high-yielding candidate…

Read more »

Black woman using smartphone at home, watching stock charts.
Growth Shares

At 112p, where next for the Lloyds share price? 168p or 56p?

Jon Smith mulls over the direction going forward for the Lloyds share price, and explains why two very different scenarios…

Read more »

Investing Articles

This dividend stock has a 7.3% yield, and Stocks and Shares ISA investors are buying!

Looking to move from a Cash ISA to a Stocks and Shares ISA to target passive income? Alan Oscroft has…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

Could Rolls-Royce shares lock in another 34% gain before Christmas?

Mark Hartley takes a look at some of the more optimistic price targets for Rolls-Royce, and considers a best-case scenario.…

Read more »

This way, That way, The other way - pointing in different directions
Investing Articles

Investec vs Aberdeen: which is the better income stock to buy?

Aiming to boost the average yield of his income portfolio, Mark Hartley's looking for new income stocks to buy on…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

Down 41% since January, this quality S&P 500 stock is stinking out my ISA

The tide's turned against this S&P 500 robotics stock. Is it time to dump it? Or is there a no-brainer…

Read more »

GSK scientist holding lab syringe
Investing Articles

By mid-2027, analysts expect £6,000 in GSK shares to be worth…

GSK shares are currently trading almost 20% below their 2026 highs. Is there potential for a rebound over the next…

Read more »

Rolls-Royce's Pearl 10X engine series
Investing Articles

Up nearly 1,400% in 5 years! But are Rolls-Royce shares still secretly undervalued?

After skyrocketing, Rolls-Royce shares are now near an all-time high, but could the engineering giant still have more room to…

Read more »